SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA concludes surveillance inspection at API unit of Kopran’s arm

29 Apr 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has concluded surveillance inspection at API unit of Kopran’s wholly owned subsidiary -- Kopran Research Laboratories. The said API unit located at Mahad in Maharashtra. The inspection was conducted from April 21, 2025 to April 25, 2025. The inspection was concluded without any observations.

Kopran is engaged primarily in pharmaceuticals business. The Company manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.

Kopran Share Price

154.90 -0.65 (-0.42%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×